Reauthorizes the Stem Cell Therapeutic and Research Act of 2005, extending funding for the C.W. Bill Young Cell Transplantation Program through 2031.
The Stem Cell Therapeutic and Research Reauthorization Act of 2025 extends the authorization of the Stem Cell Therapeutic and Research Act of 2005, which supports stem cell research and therapies. It reauthorizes funding for the C.W. Bill Young Cell Transplantation Program, ensuring continued support for cord blood inventory through 2031. This extension aims to maintain progress in stem cell research and its therapeutic applications.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.